Posted on June 4, 20266/4/26
Winning in the EU JCA Era: Why Proactive Intelligence Will Define Market Access Success
Posted on May 8, 20265/8/26
How MFN is Reshaping Global Drug Pricing – and How NAVLIN Insights Tracks It
Posted on January 14, 20261/14/26
NAVLIN Daily 2025 Round-Up: The Pricing and Policy Trends Redefining Market Access
Posted on December 10, 202512/10/25
Predicting PICOs for EU HTA: The Validated PICO Planner Approach Based on Retrospective Analysis
Posted on September 30, 20259/30/25
Strategic PICO Planning: Navigating Oncology Markets with NAVLIN by EVERSANA
Posted on September 30, 20259/30/25
Strategic PICO Planning: Enhancing Early-Phase Development for Market Access
Posted on August 25, 20258/25/25
Evaluation of HTA Frameworks for In Vivo Diagnostics: Assessing Methodological Gaps and Implications for Market Access
Posted on July 22, 20257/22/25
Case Study: Transforming Market Access with NAVLIN Insights KPI
Posted on September 30, 20249/30/24
Unlocking the Power of Tender Data to Drive Post-LOE Pricing Strategy
Posted on September 17, 20249/17/24